{
    "PMC5564609_3": [
        {
            "subject": {
                "complication": "delayed gastric emptying",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[15, 0.02]"
        },
        {
            "subject": {
                "complication": "delayed gastric emptying",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[32, 0.02]"
        },
        {
            "subject": {
                "complication": "bleeding",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[6, 0.5]"
        },
        {
            "subject": {
                "complication": "bleeding",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[4, 0.5]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[39, 0.52]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[36, 0.52]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "grade": "A",
                "group": "ERAS",
                "sample size": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[8]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "grade": "A",
                "group": "Conventional",
                "sample size": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "grade": "B",
                "group": "ERAS",
                "sample size": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[10]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "grade": "B",
                "group": "Conventional",
                "sample size": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[6]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "grade": "C",
                "group": "ERAS",
                "sample size": "76"
            },
            "measures": "[incidence]",
            "outcomes": "[21]"
        },
        {
            "subject": {
                "complication": "pancreatic fistula",
                "grade": "C",
                "group": "Conventional",
                "sample size": "83"
            },
            "measures": "[incidence]",
            "outcomes": "[24]"
        },
        {
            "subject": {
                "complication": "biliary fistula",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[2, 0.47]"
        },
        {
            "subject": {
                "complication": "biliary fistula",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[0, 0.47]"
        },
        {
            "subject": {
                "complication": "wound infection",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[5, 0.66]"
        },
        {
            "subject": {
                "complication": "wound infection",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[3, 0.66]"
        },
        {
            "subject": {
                "complication": "pulmonary complication",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[2, 0.1]"
        },
        {
            "subject": {
                "complication": "pulmonary complication",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[4, 0.1]"
        },
        {
            "subject": {
                "complication": "skin orifice infection",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 0.012]"
        },
        {
            "subject": {
                "complication": "skin orifice infection",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[6, 0.012]"
        },
        {
            "subject": {
                "complication": "abdominal abscess",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "complication": "abdominal abscess",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "complication": "pancreatitis",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[2, 1]"
        },
        {
            "subject": {
                "complication": "pancreatitis",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        },
        {
            "subject": {
                "complication": "sepsis",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        },
        {
            "subject": {
                "complication": "sepsis",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[0, 1]"
        },
        {
            "subject": {
                "complication": "re-laparotomy",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[3, 0.6]"
        },
        {
            "subject": {
                "complication": "re-laparotomy",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 0.6]"
        },
        {
            "subject": {
                "outcome": "mortality",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "outcome": "mortality",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence]",
            "outcomes": "[0]"
        },
        {
            "subject": {
                "complication": "readmission",
                "timeframe": "in 30 days",
                "group": "ERAS",
                "sample size": "76",
                "comparison": "Conventional",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        },
        {
            "subject": {
                "complication": "readmission",
                "timeframe": "in 30 days",
                "group": "Conventional",
                "sample size": "83",
                "comparison": "ERAS",
                "statistical test": "Fisher exact test"
            },
            "measures": "[incidence, P]",
            "outcomes": "[1, 1]"
        }
    ],
    "PMC3798558_1": [
        {
            "subject": {
                "characteristic": "age",
                "group": "cases",
                "total_subjects": "185",
                "age_range": "<40"
            },
            "measures": "[count, percentage]",
            "outcomes": "[10, 5.41]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "controls",
                "total_subjects": "1465",
                "age_range": "<40"
            },
            "measures": "[count, percentage]",
            "outcomes": "[75, 5.12]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "cases",
                "total_subjects": "185",
                "age_range": "\u226540 but <50"
            },
            "measures": "[count, percentage]",
            "outcomes": "[19, 10.27]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "controls",
                "total_subjects": "1465",
                "age_range": "\u226540 but <50"
            },
            "measures": "[count, percentage]",
            "outcomes": "[147, 10.03]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "cases",
                "total_subjects": "185",
                "age_range": "\u226550 but <60"
            },
            "measures": "[count, percentage]",
            "outcomes": "[60, 32.43]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "controls",
                "total_subjects": "1465",
                "age_range": "\u226550 but <60"
            },
            "measures": "[count, percentage]",
            "outcomes": "[479, 32.70]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "cases",
                "total_subjects": "185",
                "age_range": "\u226560 but <70"
            },
            "measures": "[count, percentage]",
            "outcomes": "[60, 32.43]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "controls",
                "total_subjects": "1465",
                "age_range": "\u226560 but <70"
            },
            "measures": "[count, percentage]",
            "outcomes": "[484, 33.04]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "cases",
                "total_subjects": "185",
                "age_range": "\u226570"
            },
            "measures": "[count, percentage]",
            "outcomes": "[36, 19.46]"
        },
        {
            "subject": {
                "characteristic": "age",
                "group": "controls",
                "total_subjects": "1465",
                "age_range": "\u226570"
            },
            "measures": "[count, percentage]",
            "outcomes": "[280, 19.11]"
        },
        {
            "subject": {
                "characteristic": "age",
                "statistical_test": "chi-square test"
            },
            "measures": "[p-value]",
            "outcomes": "[0.999]"
        },
        {
            "subject": {
                "characteristic": "sex",
                "group": "cases",
                "total_subjects": "185",
                "sex": "male"
            },
            "measures": "[count, percentage]",
            "outcomes": "[127, 68.65]"
        },
        {
            "subject": {
                "characteristic": "sex",
                "group": "controls",
                "total_subjects": "1465",
                "sex": "male"
            },
            "measures": "[count, percentage]",
            "outcomes": "[1097, 74.88]"
        },
        {
            "subject": {
                "characteristic": "sex",
                "group": "cases",
                "total_subjects": "185",
                "sex": "female"
            },
            "measures": "[count, percentage]",
            "outcomes": "[58, 31.35]"
        },
        {
            "subject": {
                "characteristic": "sex",
                "group": "controls",
                "total_subjects": "1465",
                "sex": "female"
            },
            "measures": "[count, percentage]",
            "outcomes": "[368, 25.12]"
        },
        {
            "subject": {
                "characteristic": "sex",
                "statistical_test": "chi-square test"
            },
            "measures": "[p-value]",
            "outcomes": "[0.068]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "<18.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[15, 8.11]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "<18.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[61, 4.16]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226518.5 but <22.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[84, 45.11]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226518.5 but <22.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[555, 37.88]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226522.5 but <25",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[47, 25.41]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226522.5 but <25",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[478, 32.63]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226525 but <27.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[25, 13.51]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226525 but <27.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[245, 16.72]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226527.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[14, 7.57]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226527.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[111, 7.58]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "unknown",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[0, 0.00]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "unknown",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[15, 1.02]"
        },
        {
            "subject": {
                "characteristic": "current BMI",
                "statistical_test": "chi-square test"
            },
            "measures": "[p-value]",
            "outcomes": "[0.021]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "<18.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[14, 7.57]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "<18.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[168, 11.47]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226518.5 but <22.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[112, 60.54]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226518.5 but <22.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[950, 64.85]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226522.5 but <25",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[36, 19.46]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226522.5 but <25",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[226, 15.43]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226525 but <27.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[11, 5.95]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226525 but <27.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[72, 4.91]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "\u226527.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[6, 3.24]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "\u226527.5",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[14, 0.96]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "cases",
                "total_subjects": "185",
                "bmi_range": "unknown",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[6, 3.24]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "group": "controls",
                "total_subjects": "1465",
                "bmi_range": "unknown",
                "unit": "kg/m^2"
            },
            "measures": "[count, percentage]",
            "outcomes": "[35, 2.39]"
        },
        {
            "subject": {
                "characteristic": "BMI at age 20",
                "statistical_test": "chi-square test"
            },
            "measures": "[p-value]",
            "outcomes": "[0.018]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "cases",
                "total_subjects": "185",
                "pack_years_range": "<5"
            },
            "measures": "[count, percentage]",
            "outcomes": "[69, 37.30]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "controls",
                "total_subjects": "1465",
                "pack_years_range": "<5"
            },
            "measures": "[count, percentage]",
            "outcomes": "[638, 43.55]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "cases",
                "total_subjects": "185",
                "pack_years_range": "\u22655 but <20"
            },
            "measures": "[count, percentage]",
            "outcomes": "[22, 11.89]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "controls",
                "total_subjects": "1465",
                "pack_years_range": "\u22655 but <20"
            },
            "measures": "[count, percentage]",
            "outcomes": "[206, 14.06]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "cases",
                "total_subjects": "185",
                "pack_years_range": "\u226520 but <40"
            },
            "measures": "[count, percentage]",
            "outcomes": "[34, 18.38]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "controls",
                "total_subjects": "1465",
                "pack_years_range": "\u226520 but <40"
            },
            "measures": "[count, percentage]",
            "outcomes": "[308, 21.02]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "cases",
                "total_subjects": "185",
                "pack_years_range": "\u226540"
            },
            "measures": "[count, percentage]",
            "outcomes": "[60, 32.43]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "controls",
                "total_subjects": "1465",
                "pack_years_range": "\u226540"
            },
            "measures": "[count, percentage]",
            "outcomes": "[304, 20.75]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "cases",
                "total_subjects": "185",
                "pack_years_range": "unknown"
            },
            "measures": "[count, percentage]",
            "outcomes": "[0, 0.00]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "group": "controls",
                "total_subjects": "1465",
                "pack_years_range": "unknown"
            },
            "measures": "[count, percentage]",
            "outcomes": "[9, 0.61]"
        },
        {
            "subject": {
                "characteristic": "cigarette pack-years",
                "statistical_test": "chi-square test"
            },
            "measures": "[p-value]",
            "outcomes": "[0.005]"
        },
        {
            "subject": {
                "characteristic": "drinking",
                "group": "cases",
                "total_subjects": "185",
                "drinking_range": "non",
                "unit": "g ethanol/day"
            },
            "measures": "[count, percentage]",
            "outcomes": "[56, 30.27]"
        },
        {
            "subject": {
                "characteristic": "drinking",
                "group": "controls",
                "total_subjects": "1465",
                "drinking_range": "non",
                "unit": "g ethanol/day"
            },
            "measures": "[count, percentage]",
            "outcomes": "[488, 33.31]"
        }
    ],
    "PMC5762325_3": [
        {
            "subject": {
                "analysis": "correlation analysis",
                "tissue type": "tumor tissue",
                "cancer type": "pancreatic cancer",
                "protein 1": "E-cadherin",
                "protein 2": "STYK1",
                "E-cadherin expression": "low",
                "STYK1 expression": "low"
            },
            "measures": "[sample count]",
            "outcomes": "[9]"
        },
        {
            "subject": {
                "analysis": "correlation analysis",
                "tissue type": "tumor tissue",
                "cancer type": "pancreatic cancer",
                "protein 1": "E-cadherin",
                "protein 2": "STYK1",
                "E-cadherin expression": "low",
                "STYK1 expression": "high"
            },
            "measures": "[sample count]",
            "outcomes": "[23]"
        },
        {
            "subject": {
                "analysis": "correlation analysis",
                "tissue type": "tumor tissue",
                "cancer type": "pancreatic cancer",
                "protein 1": "E-cadherin",
                "protein 2": "STYK1",
                "E-cadherin expression": "high",
                "STYK1 expression": "low"
            },
            "measures": "[sample count]",
            "outcomes": "[34]"
        },
        {
            "subject": {
                "analysis": "correlation analysis",
                "tissue type": "tumor tissue",
                "cancer type": "pancreatic cancer",
                "protein 1": "E-cadherin",
                "protein 2": "STYK1",
                "E-cadherin expression": "high",
                "STYK1 expression": "high"
            },
            "measures": "[sample count]",
            "outcomes": "[14]"
        },
        {
            "subject": {
                "analysis": "correlation analysis",
                "tissue type": "tumor tissue",
                "cancer type": "pancreatic cancer",
                "protein 1": "E-cadherin",
                "protein 2": "STYK1"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[-0.420, <0.001]"
        }
    ],
    "PMC3798558_3": [
        {
            "subject": {
                "gene": "XRCC1",
                "analysis": "haplotype analysis",
                "haplotype": "1",
                "SNP1": "C",
                "SNP2": "G",
                "SNP1_rs": "rs1799782",
                "SNP2_rs": "rs25487",
                "haplotype_frequency_overall": "0.439",
                "haplotype_frequency_cases": "0.433",
                "haplotype_frequency_controls": "0.442",
                "adjusted_OR": "1.00",
                "reference": "ref.",
                "sample_size_cases": "185",
                "sample_size_controls": "1465",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "statistical_method": "Haplotype-effects logistic regression for case-control data"
            }
        },
        {
            "subject": {
                "gene": "XRCC1",
                "analysis": "haplotype analysis",
                "haplotype": "2",
                "SNP1": "C",
                "SNP2": "A",
                "SNP1_rs": "rs1799782",
                "SNP2_rs": "rs25487",
                "haplotype_frequency_overall": "0.240",
                "haplotype_frequency_cases": "0.274",
                "haplotype_frequency_controls": "0.239",
                "adjusted_OR": "1.32",
                "CI": "1.01-1.71",
                "p_value": "0.042",
                "sample_size_cases": "185",
                "sample_size_controls": "1465",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "statistical_method": "Haplotype-effects logistic regression for case-control data"
            }
        },
        {
            "subject": {
                "gene": "XRCC1",
                "analysis": "haplotype analysis",
                "haplotype": "3",
                "SNP1": "T",
                "SNP2": "G",
                "SNP1_rs": "rs1799782",
                "SNP2_rs": "rs25487",
                "haplotype_frequency_overall": "0.319",
                "haplotype_frequency_cases": "0.292",
                "haplotype_frequency_controls": "0.318",
                "adjusted_OR": "1.05",
                "CI": "0.81-1.36",
                "p_value": "0.691",
                "sample_size_cases": "185",
                "sample_size_controls": "1465",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "statistical_method": "Haplotype-effects logistic regression for case-control data"
            }
        },
        {
            "subject": {
                "gene": "XRCC1",
                "analysis": "haplotype analysis",
                "haplotype": "4",
                "SNP1": "T",
                "SNP2": "A",
                "SNP1_rs": "rs1799782",
                "SNP2_rs": "rs25487",
                "haplotype_frequency_overall": "0.002",
                "haplotype_frequency_cases": "<0.001",
                "haplotype_frequency_controls": "0.002",
                "adjusted_OR": "N.E.",
                "p_value": "N.E.",
                "sample_size_cases": "185",
                "sample_size_controls": "1465",
                "adjustment_factors": "age, sex, current BMI, BMI at age 20, smoking status, drinking habit, diabetes mellitus, family history of PC",
                "statistical_method": "Haplotype-effects logistic regression for case-control data"
            }
        },
        {
            "subject": {
                "gene": "XRCC1",
                "SNP1_rs": "rs1799782",
                "SNP2_rs": "rs25487",
                "R_squared": "0.15"
            }
        }
    ],
    "PMC4423458_3": [
        {
            "subject": {
                "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                "accession": "70906435",
                "molecular weight": "56 kDa",
                "average spectral count cancer": "138.8",
                "average spectral count control": "52.1",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[2.2, 0.01481]"
        },
        {
            "subject": {
                "protein": "C4b-binding protein alpha chain precursor",
                "accession": "4502503",
                "molecular weight": "67 kDa",
                "average spectral count cancer": "37.3",
                "average spectral count control": "11.5",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[2.3, 0.04311]"
        },
        {
            "subject": {
                "protein": "Serum albumin pre-pro-protein",
                "accession": "4502027",
                "molecular weight": "69 kDa",
                "average spectral count cancer": "986.0",
                "average spectral count control": "332.8",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[2.4, 0.00006]"
        },
        {
            "subject": {
                "protein": "Vitamin D-binding protein isoform 1 precursor",
                "accession": "32483410",
                "molecular weight": "53 kDa",
                "average spectral count cancer": "51.9",
                "average spectral count control": "19.2",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[2.4, 0.03919]"
        },
        {
            "subject": {
                "protein": "Kininogen-1 isoform 2 precursor",
                "accession": "4504893",
                "molecular weight": "48 kDa",
                "average spectral count cancer": "21.3",
                "average spectral count control": "5.5",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[3.8, 0.01109]"
        },
        {
            "subject": {
                "protein": "Alpha-2-macroglobulin precursor",
                "accession": "66932947",
                "molecular weight": "163 kDa",
                "average spectral count cancer": "127.9",
                "average spectral count control": "29.3",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[3.9, 0.00618]"
        },
        {
            "subject": {
                "protein": "Haptoglobin isoform 1 pre-pro-protein",
                "accession": "4826762",
                "molecular weight": "45 kDa",
                "average spectral count cancer": "83.8",
                "average spectral count control": "18.0",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[4.2, 0.00024]"
        },
        {
            "subject": {
                "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                "accession": "70906439",
                "molecular weight": "52 kDa",
                "average spectral count cancer": "89.3",
                "average spectral count control": "17.3",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[4.3, 0.00133]"
        },
        {
            "subject": {
                "protein": "Complement C3 precursor",
                "accession": "115298678",
                "molecular weight": "187 kDa",
                "average spectral count cancer": "174.7",
                "average spectral count control": "35.6",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[4.3, 0.00612]"
        },
        {
            "subject": {
                "protein": "Myeloperoxidase precursor",
                "accession": "4557759",
                "molecular weight": "84 kDa",
                "average spectral count cancer": "70.2",
                "average spectral count control": "11.0",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[5.3, 0.02501]"
        },
        {
            "subject": {
                "protein": "Apolipoprotein A-I pre-pro-protein",
                "accession": "4557321",
                "molecular weight": "31 kDa",
                "average spectral count cancer": "29.8",
                "average spectral count control": "5.9",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[5.7, 0.02170]"
        },
        {
            "subject": {
                "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                "accession": "4503689",
                "molecular weight": "95 kDa",
                "average spectral count cancer": "63.3",
                "average spectral count control": "9.3",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[6.4, 0.00031]"
        },
        {
            "subject": {
                "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                "accession": "156523970",
                "molecular weight": "39 kDa",
                "average spectral count cancer": "7.3",
                "average spectral count control": "1.1",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[6.5, 0.00173]"
        },
        {
            "subject": {
                "protein": "Ceruloplasmin precursor",
                "accession": "4557485",
                "molecular weight": "122 kDa",
                "average spectral count cancer": "47.3",
                "average spectral count control": "5.6",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[7.5, 0.00114]"
        },
        {
            "subject": {
                "protein": "PREDICTED: complement C4-A isoform 1",
                "accession": "341916194",
                "molecular weight": "193 kDa",
                "average spectral count cancer": "32.1",
                "average spectral count control": "4.5",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[7.7, 0.01791]"
        },
        {
            "subject": {
                "protein": "Alpha-1B-glycoprotein precursor",
                "accession": "21071030",
                "molecular weight": "54 kDa",
                "average spectral count cancer": "10.9",
                "average spectral count control": "1.2",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[8.3, 0.00468]"
        },
        {
            "subject": {
                "protein": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                "accession": "31542984",
                "molecular weight": "103 kDa",
                "average spectral count cancer": "5.5",
                "average spectral count control": "0.2",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[35.4, 0.00484]"
        },
        {
            "subject": {
                "protein": "Apolipoprotein B-100 precursor",
                "accession": "105990532",
                "molecular weight": "516 kDa",
                "average spectral count cancer": "49.3",
                "average spectral count control": "1.0",
                "comparison": "cancer vs control",
                "control": "primary sclerosing cholangitis and benign strictures"
            },
            "measures": "[normalized spectral abundance factor ratio, P-value (t-test)]",
            "outcomes": "[55.7, 0.02595]"
        }
    ],
    "PMC5589562_2": [
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-145-5p",
                "accession number": "MIMAT0000437"
            },
            "measures": "[expression ratio]",
            "outcomes": "[8980.05]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-199a-5p",
                "accession number": "MIMAT0000231"
            },
            "measures": "[expression ratio]",
            "outcomes": "[1563.68]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-199b-5p",
                "accession number": "MIMAT0000263"
            },
            "measures": "[expression ratio]",
            "outcomes": "[296.31]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-136-5p",
                "accession number": "MIMAT0000448"
            },
            "measures": "[expression ratio]",
            "outcomes": "[228.24]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-137",
                "accession number": "MIMAT0000429"
            },
            "measures": "[expression ratio]",
            "outcomes": "[227.70]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-139-5p",
                "accession number": "MIMAT0000250"
            },
            "measures": "[expression ratio]",
            "outcomes": "[216.83]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-127-3p",
                "accession number": "MIMAT0000446"
            },
            "measures": "[expression ratio]",
            "outcomes": "[159.72]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-337-5p",
                "accession number": "MIMAT0004695"
            },
            "measures": "[expression ratio]",
            "outcomes": "[148.57]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-139-3p",
                "accession number": "MIMAT0004552"
            },
            "measures": "[expression ratio]",
            "outcomes": "[146.36]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-487b",
                "accession number": "MIMAT0003180"
            },
            "measures": "[expression ratio]",
            "outcomes": "[118.72]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-199a-3p+hsa-miR-199b-3p",
                "accession number": "MIMAT0000232"
            },
            "measures": "[expression ratio]",
            "outcomes": "[107.49]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-1233",
                "accession number": "MIMAT0005588"
            },
            "measures": "[expression ratio]",
            "outcomes": "[66.04]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-379-5p",
                "accession number": "MIMAT0000733"
            },
            "measures": "[expression ratio]",
            "outcomes": "[62.89]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-660-5p",
                "accession number": "MIMAT0003338"
            },
            "measures": "[expression ratio]",
            "outcomes": "[62.50]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "TAS cells",
                "comparison to": "PC cells",
                "miRNA probe ID": "hsa-miR-335-5p",
                "accession number": "MIMAT0000765"
            },
            "measures": "[expression ratio]",
            "outcomes": "[60.53]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-205-5p",
                "accession number": "MIMAT0000266"
            },
            "measures": "[expression ratio]",
            "outcomes": "[23077.19]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-200c-3p",
                "accession number": "MIMAT0000617"
            },
            "measures": "[expression ratio]",
            "outcomes": "[5968.64]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-200b-3p",
                "accession number": "MIMAT0000318"
            },
            "measures": "[expression ratio]",
            "outcomes": "[467.15]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-429",
                "accession number": "MIMAT0001536"
            },
            "measures": "[expression ratio]",
            "outcomes": "[171.07]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-196b-5p",
                "accession number": "MIMAT0001080"
            },
            "measures": "[expression ratio]",
            "outcomes": "[116.42]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-582-5p",
                "accession number": "MIMAT0003247"
            },
            "measures": "[expression ratio]",
            "outcomes": "[99.53]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-135b-5p",
                "accession number": "MIMAT0000758"
            },
            "measures": "[expression ratio]",
            "outcomes": "[87.82]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-182-5p",
                "accession number": "MIMAT0000259"
            },
            "measures": "[expression ratio]",
            "outcomes": "[55.81]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-96-5p",
                "accession number": "MIMAT0000095"
            },
            "measures": "[expression ratio]",
            "outcomes": "[53.82]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-200a-3p",
                "accession number": "MIMAT0000682"
            },
            "measures": "[expression ratio]",
            "outcomes": "[44.88]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-4284",
                "accession number": "MIMAT0016915"
            },
            "measures": "[expression ratio]",
            "outcomes": "[41.90]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-345-5p",
                "accession number": "MIMAT0000772"
            },
            "measures": "[expression ratio]",
            "outcomes": "[27.99]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-378g",
                "accession number": "MIMAT0018937"
            },
            "measures": "[expression ratio]",
            "outcomes": "[25.01]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-203",
                "accession number": "MIMAT0000264"
            },
            "measures": "[expression ratio]",
            "outcomes": "[22.43]"
        },
        {
            "subject": {
                "analysis": "miRNA expression comparison",
                "cell type": "PC cells",
                "comparison to": "TAS cells",
                "miRNA probe ID": "hsa-miR-141-3p",
                "accession number": "MIMAT0000432"
            },
            "measures": "[expression ratio]",
            "outcomes": "[21.69]"
        }
    ],
    "PMC4190529_6": [
        {
            "subject": {
                "treatment": "gemcitabine",
                "control": "5-fluorouracil",
                "phase": "3",
                "cancer type": "pancreatic cancer"
            },
            "measures": "[median survival (months), median survival control (months), one-year survival (%), one-year survival control (%), FDA approval year]",
            "outcomes": "[5.7, 4.2, 18, 2, 1996]"
        },
        {
            "subject": {
                "treatment": "gemcitabine",
                "control": "5-fluorouracil",
                "phase": "3",
                "cancer type": "pancreatic cancer",
                "side effects": "more favorable than 5-fluorouracil"
            }
        },
        {
            "subject": {
                "treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                "control": "gemcitabine",
                "phase": "3",
                "cancer type": "pancreatic cancer"
            },
            "measures": "[median survival (months), median survival control (months), one-year survival (%), one-year survival control (%), FDA approval year]",
            "outcomes": "[6.4, 6, 24, 19, 2005]"
        },
        {
            "subject": {
                "treatment": "gemcitabine + erlotinib hydrochloride (Tarceva)",
                "control": "gemcitabine",
                "phase": "3",
                "cancer type": "pancreatic cancer",
                "side effects": "less favorable than gemcitabine"
            }
        },
        {
            "subject": {
                "treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                "control": "gemcitabine",
                "phase": "3",
                "cancer type": "pancreatic cancer"
            },
            "measures": "[median survival (months), median survival control (months), one-year survival (%), one-year survival control (%), FDA approval year]",
            "outcomes": "[8.5, 6.7, 35, 22, 2013]"
        },
        {
            "subject": {
                "treatment": "gemcitabine + protein-bound paclitaxel (Abraxane)",
                "control": "gemcitabine",
                "phase": "3",
                "cancer type": "pancreatic cancer",
                "side effects": "less favorable than gemcitabine"
            }
        },
        {
            "subject": {
                "treatment": "FOLFIRINOX",
                "control": "gemcitabine",
                "phase": "2/3",
                "cancer type": "pancreatic cancer"
            },
            "measures": "[median survival (months), median survival control (months), one-year survival (%), one-year survival control (%), FDA approval]",
            "outcomes": "[11.1, 6.8, 48.4, 20.6, n/a]"
        },
        {
            "subject": {
                "treatment": "FOLFIRINOX",
                "control": "gemcitabine",
                "phase": "2/3",
                "cancer type": "pancreatic cancer",
                "side effects": "less favorable than gemcitabine"
            }
        },
        {
            "subject": {
                "treatment": "FOLFIRINOX",
                "components": "oxaliplatin, irinotecan, fluorouracil, leucovorin"
            }
        },
        {
            "subject": {
                "treatment": "cell encapsulation + ifosfamide",
                "control": "5-fluorouracil",
                "phase": "2",
                "cancer type": "pancreatic cancer"
            },
            "measures": "[median survival (months), median survival control (months), one-year survival (%), one-year survival control (%), FDA approval]",
            "outcomes": "[10, 5, 36, 18, n/a]"
        },
        {
            "subject": {
                "treatment": "cell encapsulation + ifosfamide",
                "control": "5-fluorouracil",
                "phase": "2",
                "cancer type": "pancreatic cancer",
                "side effects": "more favorable than 5-fluorouracil or gemcitabine"
            }
        },
        {
            "subject": {
                "treatment": "cell encapsulation + ifosfamide",
                "dose": "2 g/m2",
                "toxicity": "Grade 3 or Grade 4 NCI toxicities",
                "patients affected": "five",
                "median survival": "9.5 months"
            }
        }
    ],
    "PMC5675623_3": [
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression",
                "outcome": "overall survival",
                "treatment phase": "first phase I",
                "variable": "ECOG performance status",
                "contrast": "> 0 vs. 0"
            },
            "measures": "[hazard ratio (95% CI), P value]",
            "outcomes": "[1.47 (0.90, 2.41), 0.12]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression",
                "outcome": "overall survival",
                "treatment phase": "first phase I",
                "variable": "liver metastases",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio (95% CI), P value]",
            "outcomes": "[1.72 (1.01, 2.91), 0.045]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression",
                "outcome": "overall survival",
                "treatment phase": "first phase I",
                "variable": "No. of metastatic sites",
                "contrast": ">2 vs. <= 2"
            },
            "measures": "[hazard ratio (95% CI), P value]",
            "outcomes": "[1.33 (0.9, 2.25), 0.28]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression",
                "outcome": "overall survival",
                "treatment phase": "first phase I",
                "variable": "prior radiation therapy",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio (95% CI), P value]",
            "outcomes": "[1.58 (0.95, 2.61), 0.077]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression",
                "outcome": "overall survival",
                "treatment phase": "first phase I",
                "variable": "prior FOLFIRINOX",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio (95% CI), P value]",
            "outcomes": "[1.73 (1.01, 2.98), 0.046]"
        },
        {
            "subject": {
                "analysis": "multivariate Cox proportional hazards regression",
                "outcome": "overall survival",
                "treatment phase": "first phase I",
                "variable": "prior gemcitabine plus nab-paclitaxel treatment",
                "contrast": "Yes vs. No"
            },
            "measures": "[hazard ratio (95% CI), P value]",
            "outcomes": "[1.08 (0.58, 2.01), 0.80]"
        }
    ],
    "PMC4742219_3": [
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Age",
                "metric": "P value",
                "outcome": "0.874"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Gender",
                "comparison": "female vs. male",
                "metric": "P value",
                "outcome": "0.544"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Tumor size",
                "metric": "P value",
                "outcome": "0.127"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Tumor grade",
                "comparison": "Grade II vs. I",
                "metric": "P value",
                "outcome": "0.991"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Tumor grade",
                "comparison": "Grade III vs. I",
                "metric": "P value",
                "outcome": "0.906"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Lymph Nodes",
                "comparison": "yes vs. no",
                "metric": "P value",
                "outcome": "0.229"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Margin",
                "comparison": "positive vs. negative",
                "metric": "P value",
                "outcome": "0.025"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Vascular invasion",
                "comparison": "yes vs. no",
                "metric": "P value",
                "outcome": "0.967"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Perineural invasion",
                "comparison": "yes vs. no",
                "metric": "P value",
                "outcome": "0.097"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Time from surgery to first recurrence",
                "metric": "P value",
                "outcome": "0.883"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Lung + Other vs. Lung",
                "metric": "P value",
                "outcome": "0.516"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Liver + Other vs. Lung",
                "metric": "P value",
                "outcome": "0.022"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Peritoneal vs. Lung",
                "metric": "P value",
                "outcome": "< .001"
            }
        },
        {
            "subject": {
                "analysis": "Multivariable analysis for time from recurrence to death",
                "variable": "Recurrence pattern",
                "comparison": "Local vs. Lung",
                "metric": "P value",
                "outcome": "0.025"
            }
        }
    ],
    "PMC4941379_3": [
        {
            "subject": {
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG\u2212/CagA\u2212",
                "sample size": "4555",
                "cases": "5",
                "crude incidence rate": "10.42",
                "crude incidence rate unit": "per 100,000 person-years",
                "HR1 adjustment": "age, sex, education level, smoking status and alcohol consumption",
                "HR2 adjustment": "age, sex, education level, smoking status and alcohol consumption"
            },
            "measures": "[HR2, 95% CI]",
            "outcomes": "[Ref, Ref]"
        },
        {
            "subject": {
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA\u2212",
                "sample size": "1984",
                "cases": "2",
                "crude incidence rate": "9.54",
                "crude incidence rate unit": "per 100,000 person-years",
                "HR1 adjustment": "age, sex, education level, smoking status and alcohol consumption",
                "HR2 adjustment": "age, sex, education level, smoking status and alcohol consumption"
            },
            "measures": "[HR1, HR2, 95% CI lower, 95% CI upper]",
            "outcomes": "[Ref, 0.79, 0.15, 4.08]"
        },
        {
            "subject": {
                "chronic atrophic gastritis": "None",
                "H. pylori infection": "IgG+/CagA+",
                "sample size": "2295",
                "cases": "14",
                "crude incidence rate": "58.13",
                "crude incidence rate unit": "per 100,000 person-years",
                "HR1 adjustment": "age, sex, education level, smoking status and alcohol consumption",
                "HR2 adjustment": "age, sex, education level, smoking status and alcohol consumption"
            },
            "measures": "[HR1, HR2, 95% CI lower, 95% CI upper]",
            "outcomes": "[Ref, 5.05, 1.81, 14.09]"
        },
        {
            "subject": {
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG\u2212/CagA\u2212",
                "sample size": "205",
                "cases": "0",
                "crude incidence rate": "0",
                "crude incidence rate unit": "per 100,000 person-years",
                "HR1 adjustment": "age, sex, education level, smoking status and alcohol consumption",
                "HR2 adjustment": "age, sex, education level, smoking status and alcohol consumption"
            },
            "measures": "[HR1, HR2, 95% CI lower, 95% CI upper]",
            "outcomes": "[3.45, Not estimable, 1.38, 8.64]"
        },
        {
            "subject": {
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA\u2212",
                "sample size": "143",
                "cases": "1",
                "crude incidence rate": "64.61",
                "crude incidence rate unit": "per 100,000 person-years",
                "HR1 adjustment": "age, sex, education level, smoking status and alcohol consumption",
                "HR2 adjustment": "age, sex, education level, smoking status and alcohol consumption"
            },
            "measures": "[HR1, HR2, 95% CI lower, 95% CI upper]",
            "outcomes": "[3.45, 5.50, 0.63, 47.57]"
        },
        {
            "subject": {
                "chronic atrophic gastritis": "Present",
                "H. pylori infection": "IgG+/CagA+",
                "sample size": "315",
                "cases": "5",
                "crude incidence rate": "151.20",
                "crude incidence rate unit": "per 100,000 person-years",
                "HR1 adjustment": "age, sex, education level, smoking status and alcohol consumption",
                "HR2 adjustment": "age, sex, education level, smoking status and alcohol consumption"
            },
            "measures": "[HR1, HR2, 95% CI lower, 95% CI upper]",
            "outcomes": "[3.45, 12.51, 3.57, 43.22]"
        }
    ],
    "PMC3987090_4": [
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": "\u22641",
                "sample_size": "14",
                "sample_percentage": "5.6%",
                "median_OS": "12.8 months",
                "median_OS_CI_lower": "9.4 months",
                "median_OS_CI_upper": "16.2 months",
                "univariate_hazard_ratio": "1",
                "univariate_CI_lower": "0.86",
                "univariate_CI_upper": "3.29",
                "univariate_p_value": "0.13",
                "multivariate_hazard_ratio": "1",
                "multivariate_CI_lower": "0.69",
                "multivariate_CI_upper": "2.71",
                "multivariate_p_value": "0.37",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[12.8, 1, 1]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": ">1",
                "sample_size": "238",
                "sample_percentage": "94.4%",
                "median_OS": "11.7 months",
                "median_OS_CI_lower": "10.4 months",
                "median_OS_CI_upper": "13.0 months",
                "univariate_hazard_ratio": "1.68",
                "univariate_CI_lower": "0.86",
                "univariate_CI_upper": "3.29",
                "univariate_p_value": "0.13",
                "multivariate_hazard_ratio": "1.37",
                "multivariate_CI_lower": "0.69",
                "multivariate_CI_upper": "2.71",
                "multivariate_p_value": "0.37",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[11.7, 1.68, 1.37]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": "\u22642",
                "sample_size": "83",
                "sample_percentage": "32.9%",
                "median_OS": "14.8 months",
                "median_OS_CI_lower": "11.5 months",
                "median_OS_CI_upper": "18.2 months",
                "univariate_hazard_ratio": "1",
                "univariate_CI_lower": "1.13",
                "univariate_CI_upper": "2.05",
                "univariate_p_value": "0.01",
                "multivariate_hazard_ratio": "1",
                "multivariate_CI_lower": "0.88",
                "multivariate_CI_upper": "1.66",
                "multivariate_p_value": "0.24",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[14.8, 1, 1]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": ">2",
                "sample_size": "169",
                "sample_percentage": "67.1%",
                "median_OS": "10.7 months",
                "median_OS_CI_lower": "9.3 months",
                "median_OS_CI_upper": "12.1 months",
                "univariate_hazard_ratio": "1.52",
                "univariate_CI_lower": "1.13",
                "univariate_CI_upper": "2.05",
                "univariate_p_value": "0.01",
                "multivariate_hazard_ratio": "1.21",
                "multivariate_CI_lower": "0.88",
                "multivariate_CI_upper": "1.66",
                "multivariate_p_value": "0.24",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[10.7, 1.52, 1.21]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": "\u22643",
                "sample_size": "158",
                "sample_percentage": "62.7%",
                "median_OS": "13.4 months",
                "median_OS_CI_lower": "11.1 months",
                "median_OS_CI_upper": "15.7 months",
                "univariate_hazard_ratio": "1",
                "univariate_CI_lower": "1.26",
                "univariate_CI_upper": "2.23",
                "univariate_p_value": "<0.01",
                "multivariate_hazard_ratio": "1",
                "multivariate_CI_lower": "1.18",
                "multivariate_CI_upper": "2.11",
                "multivariate_p_value": "<0.01",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[13.4, 1, 1]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": ">3",
                "sample_size": "94",
                "sample_percentage": "37.3%",
                "median_OS": "8.6 months",
                "median_OS_CI_lower": "6.2 months",
                "median_OS_CI_upper": "11.0 months",
                "univariate_hazard_ratio": "1.68",
                "univariate_CI_lower": "1.26",
                "univariate_CI_upper": "2.23",
                "univariate_p_value": "<0.01",
                "multivariate_hazard_ratio": "1.57",
                "multivariate_CI_lower": "1.18",
                "multivariate_CI_upper": "2.11",
                "multivariate_p_value": "<0.01",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[8.6, 1.68, 1.57]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": "\u22644",
                "sample_size": "194",
                "sample_percentage": "77.0%",
                "median_OS": "13.3 months",
                "median_OS_CI_lower": "11.4 months",
                "median_OS_CI_upper": "15.2 months",
                "univariate_hazard_ratio": "1",
                "univariate_CI_lower": "1.44",
                "univariate_CI_upper": "2.78",
                "univariate_p_value": "<0.01",
                "multivariate_hazard_ratio": "1",
                "multivariate_CI_lower": "1.36",
                "multivariate_CI_upper": "2.67",
                "multivariate_p_value": "<0.01",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[13.3, 1, 1]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": ">4",
                "sample_size": "58",
                "sample_percentage": "23.0%",
                "median_OS": "7.3 months",
                "median_OS_CI_lower": "5.6 months",
                "median_OS_CI_upper": "9.0 months",
                "univariate_hazard_ratio": "2.00",
                "univariate_CI_lower": "1.44",
                "univariate_CI_upper": "2.78",
                "univariate_p_value": "<0.01",
                "multivariate_hazard_ratio": "1.91",
                "multivariate_CI_lower": "1.36",
                "multivariate_CI_upper": "2.67",
                "multivariate_p_value": "<0.01",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[7.3, 2.00, 1.91]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": "\u22645",
                "sample_size": "212",
                "sample_percentage": "84.1%",
                "median_OS": "12.8 months",
                "median_OS_CI_lower": "10.7 months",
                "median_OS_CI_upper": "14.9 months",
                "univariate_hazard_ratio": "1",
                "univariate_CI_lower": "1.50",
                "univariate_CI_upper": "3.15",
                "univariate_p_value": "<0.01",
                "multivariate_hazard_ratio": "1",
                "multivariate_CI_lower": "1.49",
                "multivariate_CI_upper": "3.15",
                "multivariate_p_value": "<0.01",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[12.8, 1, 1]"
        },
        {
            "subject": {
                "analysis_type": "univariate and multivariate",
                "outcome": "survival",
                "biomarker": "NLR",
                "threshold": ">5",
                "sample_size": "40",
                "sample_percentage": "15.9%",
                "median_OS": "6.0 months",
                "median_OS_CI_lower": "2.8 months",
                "median_OS_CI_upper": "9.2 months",
                "univariate_hazard_ratio": "2.17",
                "univariate_CI_lower": "1.50",
                "univariate_CI_upper": "3.15",
                "univariate_p_value": "<0.01",
                "multivariate_hazard_ratio": "2.16",
                "multivariate_CI_lower": "1.49",
                "multivariate_CI_upper": "3.15",
                "multivariate_p_value": "<0.01",
                "multivariate_adjustment": "distant metastasis, status of recurrent, CA19-9, and CEA"
            },
            "measures": "[median OS, univariate hazard ratio, multivariate hazard ratio]",
            "outcomes": "[6.0, 2.17, 2.16]"
        }
    ],
    "PMC3987090_5": [
        {
            "subject": {
                "study": "An X et al.",
                "year": "2010",
                "n": "89",
                "number of patients with NLR >5": "16",
                "percentage of patients with NLR >5": "17.9%",
                "overall survival NLR >5": "2.4 months",
                "overall survival NLR \u22645": "7.7 months",
                "hazard ratio": "4.49",
                "p-value": "0.013",
                "reference": "16",
                "condition": "APC patients receiving chemotherapy"
            },
            "measures": "[overall survival difference, hazard ratio, p-value]",
            "outcomes": "[5.3 months, 4.49, 0.013]"
        },
        {
            "subject": {
                "study": "Wang DS et al.",
                "year": "2012",
                "n": "86",
                "number of patients with NLR >5": "12",
                "percentage of patients with NLR >5": "13.9%",
                "overall survival NLR >5": "5.8 months",
                "overall survival NLR \u22645": "10.2 months",
                "reference": "17",
                "condition": "APC patients receiving chemotherapy"
            },
            "measures": "[overall survival difference]",
            "outcomes": "[4.4 months]"
        },
        {
            "subject": {
                "study": "Stotz M et al",
                "year": "2013",
                "n": "261",
                "number of patients with NLR >5": "79",
                "percentage of patients with NLR >5": "30.3%",
                "hazard ratio": "2.53",
                "p-value": "<0.01",
                "reference": "17",
                "condition": "APC patients receiving chemotherapy and no chemotherapy",
                "note": "This study (n = 261) pooled the data from patients who received chemotherapy (n = 179) and no chemotherapy (n = 82)"
            },
            "measures": "[hazard ratio, p-value]",
            "outcomes": "[2.53, <0.01]"
        },
        {
            "subject": {
                "study": "Our study",
                "year": "2013",
                "n": "253",
                "number of patients with NLR >5": "40",
                "percentage of patients with NLR >5": "15.8%",
                "overall survival NLR >5": "6.0 months",
                "overall survival NLR \u22645": "12.8 months",
                "hazard ratio": "1.95",
                "p-value": "<0.01",
                "condition": "APC patients receiving chemotherapy"
            },
            "measures": "[overall survival difference, hazard ratio, p-value]",
            "outcomes": "[6.8 months, 1.95, <0.01]"
        }
    ],
    "PMC3544459_4": [
        {
            "subject": {
                "condition": "diabetes",
                "diabetes status": "no",
                "median survival time (months)": "33.2 \u00b1 1.8",
                "analysis type": "univariate",
                "reference group": "yes"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.0, 0.049, 0.050]"
        },
        {
            "subject": {
                "condition": "diabetes",
                "diabetes status": "yes",
                "median survival time (months)": "24.6 \u00b1 2.5",
                "analysis type": "univariate",
                "reference group": "no"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.27 (1.00\u20131.60), 0.049, 0.050]"
        },
        {
            "subject": {
                "condition": "diabetes",
                "diabetes status": "no",
                "analysis type": "multivariate",
                "reference group": "yes"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.036]"
        },
        {
            "subject": {
                "condition": "diabetes",
                "diabetes status": "yes",
                "analysis type": "multivariate",
                "reference group": "no"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.29 (1.02\u20131.64), 0.036]"
        },
        {
            "subject": {
                "condition": "perineural invasion",
                "perineural invasion status": "no",
                "median survival time (months)": "51.7 \u00b1 31.1",
                "analysis type": "univariate",
                "reference group": "yes"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.0, <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "perineural invasion",
                "perineural invasion status": "yes",
                "median survival time (months)": "29.4 \u00b1 1.64",
                "analysis type": "univariate",
                "reference group": "no"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[2.01 (1.38\u20132.93), <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "perineural invasion",
                "perineural invasion status": "no",
                "analysis type": "multivariate",
                "reference group": "yes"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.019]"
        },
        {
            "subject": {
                "condition": "perineural invasion",
                "perineural invasion status": "yes",
                "analysis type": "multivariate",
                "reference group": "no"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.60 (1.08\u20132.36), 0.019]"
        },
        {
            "subject": {
                "condition": "margin status",
                "margin status": "negative",
                "median survival time (months)": "33.6 \u00b1 1.7",
                "analysis type": "univariate",
                "reference group": "positive"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.0, <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "margin status",
                "margin status": "positive",
                "median survival time (months)": "24.8 \u00b1 2.6",
                "analysis type": "univariate",
                "reference group": "negative"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.62 (1.27\u20132.08), <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "margin status",
                "margin status": "negative",
                "analysis type": "multivariate",
                "reference group": "positive"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.003]"
        },
        {
            "subject": {
                "condition": "margin status",
                "margin status": "positive",
                "analysis type": "multivariate",
                "reference group": "negative"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.47 (1.14\u20131.90), 0.003]"
        },
        {
            "subject": {
                "condition": "node status",
                "node status": "negative",
                "median survival time (months)": "38.6 \u00b1 5.3",
                "analysis type": "univariate",
                "reference group": "positive"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.0, <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "node status",
                "node status": "positive",
                "median survival time (months)": "27.5 \u00b1 1.3",
                "analysis type": "univariate",
                "reference group": "negative"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.70 (1.35\u20132.15), <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "node status",
                "node status": "negative",
                "analysis type": "multivariate",
                "reference group": "positive"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, 0.002]"
        },
        {
            "subject": {
                "condition": "node status",
                "node status": "positive",
                "analysis type": "multivariate",
                "reference group": "negative"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.45 (1.14\u20131.83), 0.002]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation status": "well\u2013moderate",
                "median survival time (months)": "35.9 \u00b1 2.68",
                "analysis type": "univariate",
                "reference group": "poor"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.0, <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation status": "poor",
                "median survival time (months)": "26.0 \u00b1 1.77",
                "analysis type": "univariate",
                "reference group": "well\u2013moderate"
            },
            "measures": "[HR (95% CI), P value (log-rank), P]",
            "outcomes": "[1.63 (1.32\u20132.02), <0.001, <0.001]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation status": "well\u2013moderate",
                "analysis type": "multivariate",
                "reference group": "poor"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.0, <0.001]"
        },
        {
            "subject": {
                "condition": "differentiation",
                "differentiation status": "poor",
                "analysis type": "multivariate",
                "reference group": "well\u2013moderate"
            },
            "measures": "[HR (95% CI), P]",
            "outcomes": "[1.63 (1.32\u20132.02), <0.001]"
        }
    ],
    "PMC3497287_3": [
        {
            "subject": {
                "inherited syndrome": "Lynch Syndrome",
                "mutated gene": "Mismatch Repair Genes (MMR): MLH1, MSH2, MSH6 and PMS2"
            }
        },
        {
            "subject": {
                "inherited syndrome": "Peutz-Jeghers Syndrome",
                "mutated gene": "STK11/LKB1"
            }
        },
        {
            "subject": {
                "inherited syndrome": "Hereditary Breast Cancer",
                "mutated gene": "BRCA1/BRCA2"
            }
        },
        {
            "subject": {
                "inherited syndrome": "Familial Atypical Multiple Mole Melanoma",
                "mutated gene": "CDKN2A mutation"
            }
        }
    ],
    "PMC4728116_3": [
        {
            "subject": {
                "characteristic": "family history of pancreatic cancer",
                "family history of pancreatic cancer": "no",
                "cases": "312",
                "cases percentage": "96.6",
                "controls": "320",
                "controls percentage": "99.1",
                "crude OR": "1.00",
                "crude CI": "reference",
                "adjusted OR1": "1.00",
                "adjusted CI1": "reference",
                "adjusted OR2": "1.00",
                "adjusted CI2": "reference"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "family history of pancreatic cancer",
                "family history of pancreatic cancer": "yes",
                "cases": "11",
                "cases percentage": "3.4",
                "controls": "3",
                "controls percentage": "0.9",
                "crude OR": "3.67",
                "crude CI": "1.02\u201313.14",
                "adjusted OR1": "4.04",
                "adjusted CI1": "1.08\u201315.07",
                "adjusted OR2": "1.23",
                "adjusted CI2": "1.11\u20133.70",
                "statistical significance": "yes"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[3.67, 4.04, 1.23]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "BMI": "<24.0",
                "cases": "197",
                "cases percentage": "61.0",
                "controls": "230",
                "controls percentage": "71.2",
                "crude OR": "1.00",
                "crude CI": "reference",
                "adjusted OR1": "1.00",
                "adjusted CI1": "reference",
                "adjusted OR2": "1.00",
                "adjusted CI2": "reference"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "BMI",
                "BMI": "\u226524.0",
                "cases": "126",
                "cases percentage": "39.0",
                "controls": "93",
                "controls percentage": "28.8",
                "crude OR": "1.67",
                "crude CI": "1.18\u20132.38",
                "adjusted OR1": "1.78",
                "adjusted CI1": "1.23\u20132.58",
                "adjusted OR2": "1.77",
                "adjusted CI2": "1.22\u20132.57",
                "statistical significance": "yes"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[1.67, 1.78, 1.77]"
        },
        {
            "subject": {
                "characteristic": "diabetes",
                "diabetes": "no",
                "cases": "174",
                "cases percentage": "78.0",
                "controls": "255",
                "controls percentage": "90.7",
                "crude OR": "1.00",
                "crude CI": "reference",
                "adjusted OR1": "1.00",
                "adjusted CI1": "reference",
                "adjusted OR2": "1.00",
                "adjusted CI2": "reference"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "diabetes",
                "diabetes": "yes",
                "cases": "49",
                "cases percentage": "22.0",
                "controls": "26",
                "controls percentage": "9.3",
                "crude OR": "2.69",
                "crude CI": "1.51\u20134.77",
                "adjusted OR1": "2.60",
                "adjusted CI1": "1.41\u20134.79",
                "adjusted OR2": "2.96",
                "adjusted CI2": "1.48\u20135.92",
                "statistical significance": "yes"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[2.69, 2.60, 2.96]"
        },
        {
            "subject": {
                "characteristic": "cholecystitis",
                "cholecystitis": "no",
                "cases": "272",
                "cases percentage": "94.1",
                "controls": "195",
                "controls percentage": "96.7",
                "crude OR": "1.00",
                "crude CI": "reference",
                "adjusted OR1": "1.00",
                "adjusted CI1": "reference",
                "adjusted OR2": "1.00",
                "adjusted CI2": "reference"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "cholecystitis",
                "cholecystitis": "yes",
                "cases": "17",
                "cases percentage": "5.9",
                "controls": "10",
                "controls percentage": "3.3",
                "crude OR": "1.89",
                "crude CI": "0.84\u20134.24",
                "adjusted OR1": "1.91",
                "adjusted CI1": "0.83\u20134.38",
                "adjusted OR2": "1.35",
                "adjusted CI2": "0.50\u20133.68",
                "statistical significance": "no"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[1.89, 1.91, 1.35]"
        },
        {
            "subject": {
                "characteristic": "gallstone",
                "gallstone": "no",
                "cases": "274",
                "cases percentage": "95.1",
                "controls": "300",
                "controls percentage": "98.4",
                "crude OR": "1.00",
                "crude CI": "reference",
                "adjusted OR1": "1.00",
                "adjusted CI1": "reference",
                "adjusted OR2": "1.00",
                "adjusted CI2": "reference"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[1.00, 1.00, 1.00]"
        },
        {
            "subject": {
                "characteristic": "gallstone",
                "gallstone": "yes",
                "cases": "14",
                "cases percentage": "4.9",
                "controls": "5",
                "controls percentage": "1.6",
                "crude OR": "2.80",
                "crude CI": "1.01\u20137.77",
                "adjusted OR1": "2.58",
                "adjusted CI1": "0.89\u20137.44",
                "adjusted OR2": "2.68",
                "adjusted CI2": "0.65\u201311.07",
                "statistical significance": "partial"
            },
            "measures": "[crude OR, adjusted OR1, adjusted OR2]",
            "outcomes": "[2.80, 2.58, 2.68]"
        }
    ],
    "PMC4741511_2": [
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "stratified according to LDH serum levels and treatment",
                "treatment group": "Sorafenib group",
                "LDH level": "\u2264 UNR",
                "patients number": "31",
                "patients percentage": "44%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[7.6 months, 12.7 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "stratified according to LDH serum levels and treatment",
                "treatment group": "Sorafenib group",
                "LDH level": "> UNR",
                "patients number": "6",
                "patients percentage": "8%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.8 months, 5.9 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "stratified according to LDH serum levels and treatment",
                "treatment group": "No Sorafenib group",
                "LDH level": "\u2264 UNR",
                "patients number": "27",
                "patients percentage": "38%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[3.3 months, 8.6 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "stratified according to LDH serum levels and treatment",
                "treatment group": "No Sorafenib group",
                "LDH level": "> UNR",
                "patients number": "7",
                "patients percentage": "10%"
            },
            "measures": "[PFS, OS]",
            "outcomes": "[2.2 months, 5.2 months]"
        },
        {
            "subject": {
                "study": "MAPS phase II",
                "population": "stratified according to LDH serum levels and treatment"
            },
            "measures": "[p-value for PFS, p-value for OS]",
            "outcomes": "[0.05, 0.0012]"
        }
    ],
    "PMC5522086_3": [
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "TP53",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-2.353, 3.34\u00d710^-32]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "NUPR1",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[log ratio, activation z-score, p-value of overlap]",
            "outcomes": "[-2.52, -3.977, 4.62\u00d710^-13]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "NKX2-3",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-3.455, 5.88\u00d710^-12]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "HNF1A",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-2.359, 8.82\u00d710^-12]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "CDKN2A",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[log ratio, activation z-score, p-value of overlap]",
            "outcomes": "[1.737, -3.219, 1.34\u00d710^-11]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "estrogen receptor",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-2.299, 9.57\u00d710^-10]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "RB1",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-4.286, 3.74\u00d710^-08]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "TCF3",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-3.116, 4.32\u00d710^-08]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "TRIM24",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-3.714, 6.26\u00d710^-07]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "BCL6",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-2.313, 1.60\u00d710^-06]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "NR5A2",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[log ratio, activation z-score, p-value of overlap]",
            "outcomes": "[-2.876, -2.7, 7.26\u00d710^-06]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "SATB1",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[log ratio, activation z-score, p-value of overlap]",
            "outcomes": "[-0.814, -2.003, 1.09\u00d710^-05]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "IRF4",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[log ratio, activation z-score, p-value of overlap]",
            "outcomes": "[2.115, -2.41, 4.24\u00d710^-05]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "RBL1",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-3.124, 1.72\u00d710^-04]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Inhibition",
                "upstream regulator": "SPDEF",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[-2.887, 2.39\u00d710^-04]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Activation",
                "upstream regulator": "STAT3",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[2.924, 5.78\u00d710^-19]"
        },
        {
            "subject": {
                "analysis": "Top 15 significant upstream transcription regulators",
                "regulation": "Activation",
                "upstream regulator": "CTNNB1",
                "activation z-score definition": "statistical parameter that determines whether an upstream transcription regulator has significantly more \"activated\" predictions than \"inhibited\" predictions (z>0) or vice versa (z<0)",
                "p-value of overlap definition": "measures whether there is a statistically significant overlap between the dataset genes and the genes that are regulated by a transcriptional regulator",
                "p-value calculation method": "Fisher's Exact Test",
                "p-value significance threshold": "< 0.01"
            },
            "measures": "[activation z-score, p-value of overlap]",
            "outcomes": "[3.359, 1.99\u00d710^-15]"
        }
    ],
    "PMC3428781_1": [
        {
            "subject": {
                "cell type": "quiescent PSCs",
                "vitamin A lipid droplets": "present",
                "\u03b1 smooth muscle actin": "absent",
                "proliferation": "limited",
                "migration": "limited",
                "extracellular matrix production": "limited",
                "matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)": "complement of MMPs and TIMPs to maintain normal ECM turnover",
                "production of cytokines": "limited",
                "capacity for phagocytosis": "absent",
                "proteomic analyses": "basal protein expression"
            }
        },
        {
            "subject": {
                "cell type": "activated PSCs",
                "vitamin A lipid droplets": "absent",
                "\u03b1 smooth muscle actin": "present",
                "proliferation": "increased",
                "migration": "increased",
                "extracellular matrix production": "increased",
                "matrix metalloproteinases (MMPs) and tissue inhibitors of matrix proteinases (TIMPs)": "change in types of MMPs and TIMPs to facilitate ECM deposition",
                "production of cytokines": "increased",
                "cytokines produced": "PDGF, TGF\u03b2, CTGF, IL1, IL6, IL15",
                "capacity for phagocytosis": "present",
                "proteomic analyses": "differential expression of proteins related to the cell cytoskeleton, cell metabolism, motility, growth and invasion"
            }
        }
    ],
    "PMC4941331_3": [
        {
            "subject": {
                "analysis": "association between nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tissue type": "tumor tissue",
                "CDH1 expression location": "cytoplasmic",
                "CDH1 expression level": "low",
                "HDAC3 expression location": "nuclear",
                "HDAC3 expression level": "low"
            },
            "measures": "[sample count]",
            "outcomes": "[34]"
        },
        {
            "subject": {
                "analysis": "association between nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tissue type": "tumor tissue",
                "CDH1 expression location": "cytoplasmic",
                "CDH1 expression level": "low",
                "HDAC3 expression location": "nuclear",
                "HDAC3 expression level": "high"
            },
            "measures": "[sample count]",
            "outcomes": "[22]"
        },
        {
            "subject": {
                "analysis": "association between nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tissue type": "tumor tissue",
                "CDH1 expression location": "cytoplasmic",
                "CDH1 expression level": "high",
                "HDAC3 expression location": "nuclear",
                "HDAC3 expression level": "low"
            },
            "measures": "[sample count]",
            "outcomes": "[4]"
        },
        {
            "subject": {
                "analysis": "association between nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tissue type": "tumor tissue",
                "CDH1 expression location": "cytoplasmic",
                "CDH1 expression level": "high",
                "HDAC3 expression location": "nuclear",
                "HDAC3 expression level": "high"
            },
            "measures": "[sample count]",
            "outcomes": "[24]"
        },
        {
            "subject": {
                "analysis": "association between nuclear HDAC3 and cytoplasmic CDH1 expression",
                "tissue type": "tumor tissue",
                "CDH1 expression location": "cytoplasmic",
                "HDAC3 expression location": "nuclear",
                "statistical test": "Spearman correlation"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[0.440, < 0.001]"
        },
        {
            "subject": {
                "analysis": "association between membrane CDH1 and nuclear HDAC3 expression",
                "tissue type": "tumor tissue",
                "CDH1 expression location": "membrane",
                "HDAC3 expression location": "nuclear",
                "statistical test": "Spearman correlation"
            },
            "measures": "[correlation coefficient, P-value]",
            "outcomes": "[-0.348, 0.001]"
        },
        {
            "subject": {
                "analysis": "association between cytoplasmic HDAC3 and CDH1 expression",
                "tissue type": "tumor tissue",
                "HDAC3 expression location": "cytoplasmic",
                "CDH1 expression location": "any",
                "statistical test": "not specified"
            },
            "measures": "[P-value]",
            "outcomes": "[> 0.05]"
        }
    ],
    "PMC6062623_3": [
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "right",
                "density (k)": "0.1"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.76, 0.002]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "right",
                "density (k)": "0.15"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.15, 0.008]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "right",
                "density (k)": "0.2"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.25, 0.006]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "right",
                "density (k)": "0.25"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.08, 0.009]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "left",
                "density (k)": "0.1"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-1.04, 0.32]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "left",
                "density (k)": "0.15"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-2.58, 0.022]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "left",
                "density (k)": "0.2"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.36, 0.005]"
        },
        {
            "subject": {
                "hypothesis": "state transition",
                "graph metric": "local efficiency",
                "hemisphere": "left",
                "density (k)": "0.25"
            },
            "measures": "[t-statistic, p-value]",
            "outcomes": "[-3.04, 0.01]"
        }
    ],
    "PMC5464866_2": [
        {
            "subject": {
                "tissue type": "cancerous tissues",
                "sample size": "88",
                "protein": "FXR",
                "analysis method": "immunohistochemistry",
                "comparison": "adjacent tissues"
            },
            "measures": "[FXR positive, FXR negative]",
            "outcomes": "[54 (61.4%), 34 (38.6%)]"
        },
        {
            "subject": {
                "tissue type": "adjacent tissues",
                "sample size": "88",
                "protein": "FXR",
                "analysis method": "immunohistochemistry",
                "comparison": "cancerous tissues"
            },
            "measures": "[FXR positive, FXR negative]",
            "outcomes": "[27 (30.7%), 61 (69.3%)]"
        },
        {
            "subject": {
                "tissue type": "cancerous tissues",
                "comparison": "adjacent tissues",
                "protein": "FXR",
                "analysis method": "immunohistochemistry"
            },
            "measures": "[statistical significance]",
            "outcomes": "[P < 0.05]"
        },
        {
            "subject": {
                "protein": "FXR",
                "analysis method": "immunohistochemistry",
                "tissue type": "cancerous tissues",
                "expression range": "negative to strong positive"
            }
        }
    ],
    "PMC5687650_6": [
        {
            "subject": {
                "analysis type": "Univariate analysis",
                "outcome measure": "Overall survival (OS)",
                "risk factor": "Gender",
                "risk factor categories": "Women or Men"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.770 (0.528-1.124), 0.175]"
        },
        {
            "subject": {
                "analysis type": "Univariate analysis",
                "outcome measure": "Overall survival (OS)",
                "risk factor": "Age",
                "risk factor categories": ">65 years or \u226465years"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.773 (0.537-1.110), 0.163]"
        },
        {
            "subject": {
                "analysis type": "Univariate analysis",
                "outcome measure": "Overall survival (OS)",
                "risk factor": "PLR",
                "risk factor categories": "high or low"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[0.922 (0.641-1.325), 0.660]"
        },
        {
            "subject": {
                "analysis type": "Univariate analysis",
                "outcome measure": "Overall survival (OS)",
                "risk factor": "NLR",
                "risk factor categories": "high or low"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.007 (0.701-1.448), 0.969]"
        },
        {
            "subject": {
                "analysis type": "Univariate analysis",
                "outcome measure": "Overall survival (OS)",
                "risk factor": "Post/pre-chemotherapy PLR ratio",
                "risk factor categories": ">1 or \u22641"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.272 (0.881-1.837), 0.199]"
        },
        {
            "subject": {
                "analysis type": "Univariate analysis",
                "outcome measure": "Overall survival (OS)",
                "risk factor": "Post/pre-chemotherapy NLR ratio",
                "risk factor categories": ">1 or \u22641"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001]"
        },
        {
            "subject": {
                "analysis type": "Multivariate analysis",
                "outcome measure": "Overall survival (OS)",
                "risk factor": "Post/pre-chemotherapy NLR ratio",
                "risk factor categories": ">1 or \u22641"
            },
            "measures": "[OR (95% CI), P value]",
            "outcomes": "[1.902 (1.290-2.803), 0.001]"
        }
    ],
    "PMC5464866_1": [
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "low",
                "time point": "0 year"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[87, 49.7%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "low",
                "time point": "2 years"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[16, 9.1%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "low",
                "time point": "4 years"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[6, 3.4%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "low",
                "time point": "6 years"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[1, 0.6%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "high",
                "time point": "0 year"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[88, 50.3%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "high",
                "time point": "2 years"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[9, 5.1%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "high",
                "time point": "4 years"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[3, 1.7%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "high",
                "time point": "6 years"
            },
            "measures": "[number at risk, percentage at risk]",
            "outcomes": "[0, 0.0%]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "low"
            },
            "measures": "[median survival time]",
            "outcomes": "[1.83 years]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "high"
            },
            "measures": "[median survival time]",
            "outcomes": "[1.78 years]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "low",
                "time point": "3 years"
            },
            "measures": "[survival rate, 95% CI lower bound, 95% CI upper bound]",
            "outcomes": "[0.4288, 0.3020, 0.6089]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "low",
                "time point": "5 years"
            },
            "measures": "[survival rate]",
            "outcomes": "[0.3127]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "high",
                "time point": "3 years"
            },
            "measures": "[survival rate, 95% CI lower bound, 95% CI upper bound]",
            "outcomes": "[0.3036, 0.1646, 0.5600]"
        },
        {
            "subject": {
                "cancer type": "pancreatic cancer",
                "factor": "FXR expression",
                "expression level": "high",
                "time point": "5 years"
            },
            "measures": "[survival rate, 95% CI lower bound, 95% CI upper bound]",
            "outcomes": "[0.2277, 0.0989, 0.5241]"
        }
    ],
    "PMC5641200_3": [
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Red blood cells count decreased",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[5, 83]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Red blood cells count decreased",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Red blood cells count decreased",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[2, 50]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Leukopenia",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[3, 50]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Leukopenia",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Leukopenia",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[2, 50]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Leukopenia",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Neutropenia",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[4, 67]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Neutropenia",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Neutropenia",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "AST increase",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[3, 50]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "AST increase",
                "grade": "G3"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "AST increase",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[4, 100]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "ALT increase",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[4, 67]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "ALT increase",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "ALT increase",
                "grade": "G3"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "ALT increase",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[3, 75]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "GGT increase",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "GGT increase",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Hypocalcemia",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Hypocalcemia",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[2, 33]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Hypocalcemia",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Hypocalcemia",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Hyponatremia",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Hyponatremia",
                "grade": "G3"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 17]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Hyponatremia",
                "grade": "G3"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Nausea",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[3, 50]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Nausea",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[2, 50]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Nausea",
                "grade": "G3"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Vomiting",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[2, 33]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Vomiting",
                "grade": "G3"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Diarrhea",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[2, 33]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 1",
                "dose": "<100 mg",
                "number of patients": "6",
                "adverse event": "Diarrhea",
                "grade": "G3"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[2, 33]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Diarrhea",
                "grade": "G1"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        },
        {
            "subject": {
                "treatment": "dasatinib",
                "adverse event classification": "NCI-CTCAE v4.03",
                "dose level": "Level 2",
                "dose": "100 mg",
                "number of patients": "4",
                "adverse event": "Diarrhea",
                "grade": "G2"
            },
            "measures": "[number of patients, percentage]",
            "outcomes": "[1, 25]"
        }
    ],
    "PMC5716794_2": [
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "55 mm^2",
                "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s",
                "AUC": "0.687 \u00b1 0.079",
                "AUC CI": "0.575\u22120.785",
                "sensitivity": "89.1%",
                "sensitivity CI": "78.8\u221295.5%",
                "specificity": "50.0%",
                "specificity CI": "26.0\u221274.0%",
                "PPV": "86.4%",
                "NPV": "56.3%",
                "accuracy": "80.5%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.687, 89.1, 50.0, 86.4, 56.3, 80.5]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "82 mm^2",
                "optimal cutoff value": "1.72 \u00d7 10^-3 mm^2/s",
                "AUC": "0.694 \u00b1 0.077",
                "AUC CI": "0.582\u22120.791",
                "sensitivity": "90.6%",
                "sensitivity CI": "80.7\u221296.5%",
                "specificity": "50.0%",
                "specificity CI": "26.0\u221274.0%",
                "PPV": "86.6%",
                "NPV": "59.9%",
                "accuracy": "81.7%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.694, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "99 mm^2",
                "optimal cutoff value": "1.73 \u00d7 10^-3 mm^2/s",
                "AUC": "0.707 \u00b1 0.074",
                "AUC CI": "0.596\u22120.802",
                "sensitivity": "90.6%",
                "sensitivity CI": "80.7\u221296.5%",
                "specificity": "50.0%",
                "specificity CI": "26.0\u221274.0%",
                "PPV": "86.6%",
                "NPV": "59.9%",
                "accuracy": "81.7%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.707, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "134 mm^2",
                "optimal cutoff value": "1.74 \u00d7 10^-3 mm^2/s",
                "AUC": "0.731 \u00b1 0.070",
                "AUC CI": "0.622\u22120.823",
                "sensitivity": "90.6%",
                "sensitivity CI": "80.7\u221296.5%",
                "specificity": "50.0%",
                "specificity CI": "26.0\u221274.0%",
                "PPV": "86.6%",
                "NPV": "59.9%",
                "accuracy": "81.7%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.731, 90.6, 50.0, 86.6, 59.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "152 mm^2",
                "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s",
                "AUC": "0.751 \u00b1 0.067",
                "AUC CI": "0.643\u22120.840",
                "sensitivity": "89.1%",
                "sensitivity CI": "78.8\u221295.5%",
                "specificity": "55.6%",
                "specificity CI": "30.8\u221278.5%",
                "PPV": "87.7%",
                "NPV": "58.9%",
                "accuracy": "81.7%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.751, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "161 mm^2",
                "optimal cutoff value": "1.70 \u00d7 10^-3 mm^2/s",
                "AUC": "0.756 \u00b1 0.065",
                "AUC CI": "0.649\u22120.844",
                "sensitivity": "89.1%",
                "sensitivity CI": "78.8\u221295.5%",
                "specificity": "55.6%",
                "specificity CI": "30.8\u221278.5%",
                "PPV": "87.7%",
                "NPV": "58.9%",
                "accuracy": "81.7%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.756, 89.1, 55.6, 87.7, 58.9, 81.7]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "189 mm^2",
                "optimal cutoff value": "1.75 \u00d7 10^-3 mm^2/s",
                "AUC": "0.770 \u00b1 0.062",
                "AUC CI": "0.664\u22120.856",
                "sensitivity": "90.6%",
                "sensitivity CI": "80.7\u221296.5%",
                "specificity": "55.6%",
                "specificity CI": "30.8\u221278.5%",
                "PPV": "87.9%",
                "NPV": "62.5%",
                "accuracy": "82.9%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.770, 90.6, 55.6, 87.9, 62.5, 82.9]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "214 mm^2",
                "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s",
                "AUC": "0.788 \u00b1 0.059",
                "AUC CI": "0.684\u22120.871",
                "sensitivity": "92.2%",
                "sensitivity CI": "82.7\u221297.4%",
                "specificity": "55.6%",
                "specificity CI": "30.8\u221278.5%",
                "PPV": "88.1%",
                "NPV": "66.7%",
                "accuracy": "84.2%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.788, 92.2, 55.6, 88.1, 66.7, 84.2]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "223 mm^2",
                "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s",
                "AUC": "0.793 \u00b1 0.058",
                "AUC CI": "0.689\u22120.874",
                "sensitivity": "93.8%",
                "sensitivity CI": "84.8\u221298.3%",
                "specificity": "55.6%",
                "specificity CI": "30.8\u221278.5%",
                "PPV": "88.3%",
                "NPV": "71.6%",
                "accuracy": "85.4%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.793, 93.8, 55.6, 88.3, 71.6, 85.4]"
        },
        {
            "subject": {
                "analysis": "ROC analysis",
                "comparison": "pancreatic adenocarcinoma vs healthy pancreas",
                "ROI size": "245 mm^2",
                "optimal cutoff value": "1.79 \u00d7 10^-3 mm^2/s",
                "AUC": "0.800 \u00b1 0.056",
                "AUC CI": "0.697\u22120.881",
                "sensitivity": "95.3%",
                "sensitivity CI": "86.9\u221299.0%",
                "specificity": "55.6%",
                "specificity CI": "30.8\u221278.5%",
                "PPV": "88.4%",
                "NPV": "76.9%",
                "accuracy": "86.6%"
            },
            "measures": "[AUC, sensitivity, specificity, PPV, NPV, accuracy]",
            "outcomes": "[0.800, 95.3, 55.6, 88.4, 76.9, 86.6]"
        }
    ],
    "PMC3757392_2": [
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell line": "Capan-1",
                "ICC": "++",
                "flow cytometry": "40",
                "confocal microscopy": "++",
                "Do": "170 kBq"
            },
            "measures": "[ICC, flow cytometry, confocal microscopy, Do]",
            "outcomes": "[++, 40, ++, 170]"
        },
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell line": "Cfpac-1",
                "ICC": "+++",
                "flow cytometry": "500",
                "confocal microscopy": "+++",
                "Do": "140 kBq"
            },
            "measures": "[ICC, flow cytometry, confocal microscopy, Do]",
            "outcomes": "[+++, 500, +++, 140]"
        },
        {
            "subject": {
                "vector": "C595:MUC1",
                "cell line": "Panc-1",
                "ICC": "+++",
                "flow cytometry": "80",
                "confocal microscopy": "+++",
                "Do": "160 kBq"
            },
            "measures": "[ICC, flow cytometry, confocal microscopy, Do]",
            "outcomes": "[+++, 80, +++, 160]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell line": "Capan-1",
                "ICC": "++",
                "flow cytometry": "88",
                "confocal microscopy": "++",
                "Do": "190 kBq"
            },
            "measures": "[ICC, flow cytometry, confocal microscopy, Do]",
            "outcomes": "[++, 88, ++, 190]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell line": "Cfpac-1",
                "ICC": "+++",
                "flow cytometry": "92",
                "confocal microscopy": "+++",
                "Do": "130 kBq"
            },
            "measures": "[ICC, flow cytometry, confocal microscopy, Do]",
            "outcomes": "[+++, 92, +++, 130]"
        },
        {
            "subject": {
                "vector": "394:uPA",
                "cell line": "Panc-1",
                "ICC": "+++",
                "flow cytometry": "91",
                "confocal microscopy": "+++",
                "Do": "170 kBq"
            },
            "measures": "[ICC, flow cytometry, confocal microscopy, Do]",
            "outcomes": "[+++, 91, +++, 170]"
        },
        {
            "subject": {
                "vector": "2200-2500",
                "cell line": "all cells",
                "Do": "2200-2500 kBq"
            }
        }
    ]
}